Stella Pharma (4888.T) Earnings Analysis

Stella Pharma (4888.T) next reports earnings on 2026-08-13. Trailing P/E -13.34.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4888.T next report earnings?

Next earnings date2026-08-13
Consensus EPS estimaten/a
Revenue estimaten/a

4888.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-12-6 JPYn/an/an/a
2025-11-13-4.45 JPYn/an/an/a
2025-08-07-4.6 JPYn/an/an/a
2025-05-097.05 JPYn/an/an/a
2025-02-12-3.06 JPYn/an/an/a
2024-11-08-3.09 JPYn/an/an/a

4888.T valuation and analyst view

Trailing P/E-13.34
Trailing EPS-22.95329 JPY
Price / book4.29
Dividend yield0.00%
Market cap11.09B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Stella Pharma (4888.T)'s next earnings date?

Stella Pharma is next scheduled to report on 2026-08-13.

Did 4888.T beat earnings last quarter?

Consensus estimate data was not available for 4888.T's 2026-02-12 report.

What is 4888.T's current P/E ratio and EPS?

4888.T trades at a trailing P/E of -13.34 on trailing EPS of -22.953294926812063 JPY.

What do analysts rate 4888.T?

4888.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.